Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by fivenineon May 08, 2018 6:12pm

124 Views

Post# 28000880

RE:RE:RE:RE:RE:re; Clinical Trial

So, the US trials are formally announced and lead clinical investigator has been named, awesome NR. While pretty much every step thus far has consumed more time than I would have predicted, the Sernova team continue to march forward, laying stone upon stone, building toward an amazing and worthwhile end...providing a platform that can potentially "cure" a number of serious illnesses and/or at the least, significantly improving the lives of patients with those diseases. I'm proud of the work that has been accomplished to date and eagerly look forward to seeing the next steps unfold!

!!!Congratulations to Sernova!!!

Bullboard Posts

How one company is disrupting PoC testing